Oruka Therapeutics COO Laura Sandler's Stock Transactions and Warrant Exercise

This SEC Form 4 filing reports multiple transactions by Laura Sandler, Chief Operating Officer of Oruka Therapeutics, Inc. (ORKA), on May 1, 2026. Sandler exercised 5,000 employee warrants at $7.80 per share, acquiring 5,000 shares of common stock. Concurrently, she sold a total of 5,000 shares across multiple transactions at prices ranging from $62.33 to $68.48 per share. The sales were executed pursuant to a Rule 10b5-1 trading plan established on September 19, 2025. Following these transactions, Sandler's ownership position decreased from 241,984 shares to 236,984 shares of common stock, while her remaining warrant position stands at 84,996 shares exercisable at $7.80. The warrant vesting schedule indicates 1/48 of the underlying shares vest monthly from April 3, 2025. These transactions represent a net sale of shares by the company's COO, though the exercise and sale appear to be coordinated as part of a planned trading strategy.